Badr Al-Bawardy

13PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityImmunogenetics (incl. genetic immunology)Predictive and prognostic markersTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 25, 2026
Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease.

|Feb 12, 2026
Advanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis.

Darrick K Li, Abdelkader Chaar, Tarek Arabi

|Nov 13, 2025
Prevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease.

Hend Almuhaya, Raghad Alsalamah, Asma Sallam

|Sep 22, 2025
Outcomes of Outpatient Advanced Therapy Exposed Patients Hospitalized With Severe Ulcerative Colitis.

Badr Al-Bawardy, Eman Al Sulais, Fatimah AlHarthi

|Aug 18, 2025
Editorial: Redefining Safety in Post-Liver Transplant IBD-Why Therapeutic Effectiveness Is the Ultimate Shield.

Mohammed Nabil Quraishi, Badr Al-Bawardy

|Jul 29, 2025
Efficacy and Safety of 1 L PEG-ASC Preparation for Colonoscopy in Patients with Inflammatory Bowel Diseases: A Multicenter Observational Study.

Antonio Facciorusso, Elisa Stasi, Armando Dell'Anna

Pageof 3

Frequent Collaborators

4 joint publications

Turki AlAmeel

2 joint publications

Nahla A Azzam

2 joint publications

Abdulelah Almutairdi

2 joint publications

Hajer Y Almudaiheem